
Dubai, United Arab Emirates – Wednesday, February 22nd 2012 [ME NewsWire] The incredible strides in the treatment of cardiovascular disease over the past 50 years, new imaging modalities pave the way to detailed history of myocardial infarction, with all this and a host of new ideas comes – Weneed to talk, listen and discuss – [...]

Abu Dhabi, United Arab Emirates – Thursday, February 16th 2012 [ME NewsWire] Researchers from the Massachusetts Institute of Technology (MIT), the University of California, San Diego (UCSD), Masdar Institute, and the University of Southampton are collaborating to tackle the MyHeartMap Challenge, using social networks and crowdsourcing. Launched by the University of Pennsylvania, MyHeartMap Challenge invites [...]
February 16, 2012 | Posted in
Health and Beauty,
Other |
Read More »

New Brazilian Joint Venture to Combine Local and Global Commercial Expertise WHITEHOUSE STATION, N.J. – Wednesday, February 15th 2012 [ME NewsWire] (BUSINESS WIRE)– Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the formation of a new joint venture (JV) with Supera Farma Laboratorios S.A., a Brazilian pharmaceutical company co-owned by [...]

SAN DIEGO – Wednesday, February 15th 2012 [ME NewsWire] (BUSINESS WIRE)– Pathway Genomics, a genetic testing laboratory specializing in genetic testing for nutrition and exercise response, inherited disease, prescription drug response and health condition risks, has received membership in the American Clinical Laboratory Association (ACLA). As the nation’s leading industry group to advocate lab [...]
February 15, 2012 | Posted in
Health and Beauty,
Other |
Read More »

SINGAPORE – Monday, February 13th 2012 [ME NewsWire] (BUSINESS WIRE)– Heartbeat Experts reported today selling 20 KOL identificationand KOL managementsoftware projects in the Asia-Pacific region in the fourth quarter of 2011. These projects include implementations in China, Japan, Korea, India, Indonesia and Australia. The company reported that its clients span pharmaceutical, medical device and diagnostics [...]
February 13, 2012 | Posted in
Health and Beauty,
Other |
Read More »

Dubai, United Arab Emirates – Monday, February 6th 2012 [ME NewsWire] Faces, the leading beauty destination for all of your fragrance, skincare and makeup desires presents you with an array of fragrances this Valentine’s Day! Valentine’s Day is a day of sharing with loved ones, a day of pampering and telling those that are close [...]

DARMSTADT, Germany – Saturday, February 4th 2012 [ME NewsWire] Phase III soft tissue sarcoma trial ongoing; randomized Phase II pancreatic cancer trial expected to report in February 2012 Deal provides Threshold with an upfront payment of € 19 million ($25 million), plus further potential milestones and royalties as well as an option to co-commercialize in [...]

SAVANNAH, Ga. – Thursday, February 2nd 2012 [ME NewsWire] MelApp Named One of the Top Ten Apps that can Save Your Life in Parade Magazine (BUSINESS WIRE)– Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment, today debuts its popular MelApp [...]
February 2, 2012 | Posted in
Health and Beauty,
Other |
Read More »

INGELHEIM, Germany & INDIANAPOLIS – Wednesday, February 1st 2012 [ME NewsWire] New treatment combines DPP-4 inhibitor, linagliptin (the active ingredient in Trajenta™ [linagliptin] tablets), and metformin in a single tablet, taken twice-daily, to lower blood glucose in adults with Type 2 Diabetes (BUSINESS WIRE)–For Non-U.S. and Non-UK Media Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly [...]

Physicians request Solitaire™ FR device for randomized, open-label multi-center study MANSFIELD, Mass. – Monday, January 30th 2012 [ME NewsWire] (BUSINESS WIRE)– Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the Solitaire™ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial. The Solitaire [...]